Exhibit 4.1
STOCKHOLDERS
AGREEMENT
by and among
STREAM GLOBAL SERVICES,
INC.,
ARES CORPORATE OPPORTUNITIES FUND
II, L.P.,
EGS DUTCHCO, B.V.,
NEWBRIDGE INTERNATIONAL
INVESTMENT LTD.,
MR. R. SCOTT
MURRAY
and
TRILLIUM CAPITAL
LLC
Dated as of August 14,
2009
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
1.
|
|
EFFECTIVENESS;
DEFINITIONS
|
|
2
|
|
|
|
|
|
|
1.1
|
|
Effectiveness
|
|
2
|
|
|
1.2
|
|
Definitions
|
|
2
|
|
|
|
|
2.
|
|
VOTING
AGREEMENT AMONG VOTING INVESTORS
|
|
2
|
|
|
|
|
|
|
2.1
|
|
Board of
Directors
|
|
2
|
|
|
2.2
|
|
Irrevocable
Proxy
|
|
7
|
|
|
2.3
|
|
Nomination
|
|
7
|
|
|
2.4
|
|
Period
|
|
7
|
|
|
|
|
3.
|
|
TRANSFER
RESTRICTIONS
|
|
8
|
|
|
|
|
|
|
3.1
|
|
Transfers
Prohibited
|
|
8
|
|
|
3.2
|
|
Transferees to
Become Parties
|
|
9
|
|
|
3.3
|
|
Restrictions on
Transfers to Competitors
|
|
9
|
|
|
3.4
|
|
Other
Restrictions on Transfer
|
|
9
|
|
|
3.5
|
|
Impermissible
Transfers
|
|
9
|
|
|
|
|
4.
|
|
RIGHT OF FIRST
OFFER, TAG ALONG RIGHTS, DRAG ALONG RIGHTS
|
|
10
|
|
|
|
|
|
|
4.1
|
|
Right of First
Offer
|
|
10
|
|
|
4.2
|
|
Tag
Along
|
|
12
|
|
|
4.3
|
|
Sale Event Drag
Along
|
|
14
|
|
|
4.4
|
|
Miscellaneous
Sale Provisions
|
|
15
|
|
|
|
|
5.
|
|
RIGHT OF
PARTICIPATION
|
|
18
|
|
|
|
|
|
|
5.1
|
|
Right of
Participation
|
|
18
|
|
|
5.2
|
|
Warrant
Participation Rights
|
|
21
|
|
|
5.3
|
|
Excluded
Transactions
|
|
22
|
|
|
5.4
|
|
Other
Participation Terms
|
|
23
|
|
|
|
|
6.
|
|
APPROVAL
RIGHTS
|
|
24
|
|
|
|
|
|
|
6.1
|
|
Unanimous
Stockholder Approval Rights
|
|
24
|
|
|
6.2
|
|
Other
Stockholder Approval Rights
|
|
25
|
|
|
6.3
|
|
Board Approval
Requirements
|
|
26
|
|
|
|
|
7.
|
|
ADDITIONAL
AGREEMENTS
|
|
26
|
|
|
|
|
|
|
7.1
|
|
Inspection
|
|
26
|
|
|
7.2
|
|
Financial
Statements and Other Information
|
|
27
|
|
|
7.3
|
|
Directors’ and Officers’ Insurance;
Indemnification Agreement
|
|
28
|
|
|
7.4
|
|
Other Business
Opportunities
|
|
28
|
|
|
7.5
|
|
Confidentiality
|
|
29
|
|
|
7.6
|
|
Reimbursement
and Obligation to Pay Fees
|
|
30
|
- i -
TABLE OF CONTENTS
(continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
8.
|
|
REMEDIES
|
|
31
|
|
|
|
|
9.
|
|
LEGENDS
|
|
31
|
|
|
|
|
|
|
9.1
|
|
Restrictive
Legend
|
|
31
|
|
|
9.2
|
|
1933 Act
Legend
|
|
31
|
|
|
9.3
|
|
Stop Transfer
Instruction
|
|
31
|
|
|
9.4
|
|
Termination of
1933 Act Legend
|
|
32
|
|
|
9.5
|
|
Book-Entry
Shares
|
|
32
|
|
|
|
|
10.
|
|
AMENDMENT,
TERMINATION, ETC.
|
|
32
|
|
|
|
|
|
|
10.1
|
|
Oral
Amendments
|
|
32
|
|
|
10.2
|
|
Written
Amendments
|
|
32
|
|
|
10.3
|
|
Termination
|
|
33
|
|
|
10.4
|
|
Effect of
Termination
|
|
33
|
|
|
|
|
11.
|
|
DEFINITIONS,
ETC.
|
|
33
|
|
|
|
|
|
|
11.1
|
|
Certain Matters
of Construction
|
|
33
|
|
|
11.2
|
|
Definitions
|
|
34
|
|
|
|
|
12.
|
|
MISCELLANEOUS
|
|
44
|
|
|
|
|
|
|
12.1
|
|
Stock Incentive
Plan
|
|
44
|
|
|
12.2
|
|
Authority;
Effect
|
|
44
|
|
|
12.3
|
|
Notices
|
|
44
|
|
|
12.4
|
|
Binding Effect;
Etc.
|
|
47
|
|
|
12.5
|
|
Counterparts
|
|
47
|
|
|
12.6
|
|
Severability
|
|
47
|
|
|
12.7
|
|
No
Recourse
|
|
48
|
|
|
12.8
|
|
Reimbursement
of Expenses
|
|
48
|
|
|
|
|
13.
|
|
GOVERNING
LAW
|
|
48
|
|
|
|
|
|
|
13.1
|
|
Governing
Law
|
|
48
|
|
|
13.2
|
|
Consent to
Jurisdiction
|
|
49
|
|
|
13.3
|
|
WAIVER OF JURY
TRIAL
|
|
49
|
|
|
13.4
|
|
Exercise of
Rights and Remedies
|
|
50
|
- ii -
STOCKHOLDERS
AGREEMENT
This Stockholders Agreement (the
“ Agreement ”) is made as of August 14,
2009 and is by and among
(i) Stream Global Services, Inc., a
Delaware corporation (the “ Company
”);
(ii) Ares Corporate Opportunities
Fund II, L.P., a Delaware limited partnership (“ Ares
”; together with its Permitted Transferees, if any, that
become parties to this Agreement as “ Investors
” in accordance with Section 3.2, the “ Ares
Investors ”);
(iii) EGS Dutchco B.V., a
Netherlands corporation (“ PEP ”; together with
its Permitted Transferees, if any, that become parties to this
Agreement as “ Investors ” in accordance with
Section 3.2, the “ PEP Investors
”);
(iv) NewBridge International
Investment Ltd., a British Virgin Islands company (“
Ayala ”; together with its Permitted Transferees, if
any, that become parties to this Agreement as “
Investors ” in accordance with Section 3.2, the
“ Ayala Investors ”);
(v) Mr. R. Scott Murray, a
resident of Wellesley Massachusetts (“ Mr. Murray
”; together with his Permitted Transferees, if any, that
become parties to this Agreement as “ Investors
” in accordance with Section 3.2, the “ Murray
Investors ”); and
(vi) Trillium Capital LLC, a
Delaware limited liability company (“ Trillium
”; together with its Permitted Transferees, if any, that
become parties to this Agreement as “ Investors
” in accordance with Section 3.2, the “
Trillium Investors ”).
RECITALS
1. The Company is party to the Share
Exchange Agreement, dated as of the date hereof (the “
Exchange Agreement ”), by and among the Company, EGS
Corp., Ayala and PEP, pursuant to which the Company has agreed to
acquire (the “ Transaction ”) all of the issued
and outstanding shares of EGS Corp. (the “ EGS Corp.
Shares ”).
2. In connection with the closing of
the Transaction (the “ Closing ”), (a) the
Company will issue shares of Common Stock and/or Non-Voting Common
Stock to Ayala and PEP in exchange for all of the EGS Corp. Shares
and (b) the Company will issue shares of Common Stock to Ares
upon conversion of all of the issued and outstanding shares of
preferred stock of the Company and in exchange for warrants to
purchase 7,500,000 shares of Common Stock held by Ares.
3. The parties believe that it is in
the best interests of the Company and the Investors to set forth in
this Agreement their agreements on certain matters.
AGREEMENT
Therefore, the parties hereto hereby
agree as follows:
1. EFFECTIVENESS;
DEFINITIONS.
1.1 Effectiveness . This
Agreement is being entered into before, but will not become
effective until, the consummation of the Transaction. If the
Exchange Agreement is terminated prior to the consummation of the
Transaction, then this Agreement will automatically terminate. Upon
the effectiveness of this Agreement, the Stockholder’s
Agreement dated as of August 7, 2008 by and between the
Company and Ares shall terminate and be of no further force or
effect.
1.2 Definitions . Certain
terms are used in this Agreement as specified in Section 11.2.
For purposes of this Agreement, each share of Non-Voting Common
Stock shall be deemed to be the share of Common Stock issuable upon
conversion of such share of Non-Voting Common Stock, whether or not
then convertible.
2. VOTING AGREEMENT AMONG VOTING
INVESTORS.
2.1 Board of Directors
.
2.1.1 Board Size . Each
Voting Investor hereby agrees to take all necessary actions to
cause the size of the board of directors of the Company (the
“ Board ”) to be fixed at the number of
directors elected in accordance with Section 2.1.2, which
number shall initially be ten (10).
2.1.2 Designation of
Directors . Each Voting Investor hereby agrees to cast all
votes to which such Voting Investor is entitled in respect of the
Shares, whether at any annual or special meeting, by written
consent or otherwise, so as to elect as the members of the
Board:
(a) (i) a total of three
(3) directors designated by the Ares Significant Investor for
so long as such Ares Significant Investor, together with its
Affiliates, continues to own Shares representing (A) at least
two-thirds of the total number of Shares owned by Ares and its
Affiliates upon the Closing and (B) at least fifteen percent
(15%) of the then outstanding shares of Common Stock; or
(ii) a total of two (2) directors designated by the Ares
Significant Investor for so long as such Ares Significant Investor,
together with its Affiliates, continues to own Shares representing
(A) at least fifty percent (50%) of the total number of
Shares owned by Ares and its Affiliates upon the Closing and
(B) at least seven and one-half percent (7.5%) of the
then outstanding shares of Common Stock; or (iii) one
(1) director designated by the Ares Significant Investor for
so long as the Ares Significant Investor, together with its
Affiliates, continues to own Shares representing at least
twenty-five percent (25%) of the total number of Shares owned
by Ares and its Affiliates upon the Closing;
(b) (i) a total of three
(3) directors designated by the Ayala Significant Investor and
the PEP Significant Investor (by action of the holders of a
majority of the Shares owned by the Ayala Significant Investor and
the PEP Significant Investor) for so long as such Ayala Significant
Investor and such PEP Significant
- 2 -
Investor, together with their respective
Affiliates, collectively continue to own Shares representing
(A) at least two-thirds of the total number of Shares owned by
Ayala, PEP and their respective Affiliates upon the Closing and
(B) at least fifteen percent (15%) of the then
outstanding shares of Common Stock; or (ii) a total of two
(2) directors designated by the Ayala Significant Investor and
the PEP Significant Investor (by action of the holders of a
majority of the Shares owned by the Ayala Significant Investor and
the PEP Significant Investor) for so long as such Ayala Significant
Investor and such PEP Significant Investor, together with their
respective Affiliates, collectively continue to own Shares
representing (A) at least fifty percent (50%) of the
total number of Shares owned by Ayala, PEP and their respective
Affiliates upon the Closing and (B) at least seven and
one-half percent (7.5%) of the then outstanding shares of
Common Stock; or (iii) one (1) director designated by the
Ayala Significant Investor and the PEP Significant Investor (by
action of the holders of a majority of the Shares owned by the
Ayala Significant Investor and the PEP Significant Investor) for so
long as such Ayala Significant Investor and such PEP Significant
Investor, together with their respective Affiliates, collectively
continue to own Shares representing at least twenty-five percent
(25%) of the total number of Shares owned by Ayala, PEP and
their respective Affiliates upon the Closing;
(c) one Independent Director
designated by the Board with Requisite Board Approval;
provided , that such Independent Director shall be
Mr. Paul Joubert until Mr. Joubert’s successor is
duly elected and qualified, or until Mr. Joubert’s
death, or until Mr. Joubert’s earlier disqualification,
resignation, retirement or removal;
(d) one Independent Director
designated (i) by the Ares Significant Investor for so long as
the Ares Significant Investor, together with its Affiliates,
continues to own Shares representing (A) at least one-third of
the total number of Shares owned by Ares and its Affiliates upon
the Closing or (B) at least fifteen percent (15%) of the
then outstanding shares of Common Stock and (ii) thereafter,
by the Board with Requisite Board Approval;
(e) one Independent Director
designated (i) by the Ayala Significant Investor and the PEP
Significant Investor (by action of the holders of a majority of the
Shares owned by the Ayala Significant Investor and the PEP
Significant Investor) for so long as the Ayala Significant Investor
and the PEP Significant Investor, together with their respective
Affiliates, collectively continue to own Shares representing
(A) at least one-third of the total number of Shares owned by
Ayala, PEP and their respective Affiliates upon the Closing or
(B) at least fifteen percent (15%) of the then
outstanding shares of Common Stock and (ii) thereafter, by the
Board with Requisite Board Approval; and
(f) the individual who holds the
position of Chief Executive Officer of the Company from time to
time.
Each of the members of the Board
elected pursuant to this Section 2.1.2 (other than the members
of the Board elected pursuant to clauses (c) or
(f) hereof) is referred to herein as a “ Significant
Investor Director. ” The PEP Significant Investor and the
Ayala Significant
- 3 -
Investor (by action of the holders of a majority
of the Shares owned by the Ayala Significant Investor and the PEP
Significant Investor) shall inform the Company with respect to
directors that from time to time are designated pursuant to clauses
(b) or (e) hereof whether such director shall be referred
to herein as a “ PEP Director ” or an “
Ayala Director. ” Any director designated by the Ares
Significant Investor pursuant to clauses (a) or
(d) hereof shall be referred to herein as an “ Ares
Director. ”
2.1.3 Removal; Replacement;
Vacancies . No Voting Investor shall cast any vote to which
such Voting Investor is entitled in respect of the Shares, whether
at any annual meeting or special meeting, by written consent or
otherwise, to remove any member of the Board elected pursuant to
Section 2.1.2 (other than clause (f) thereof) except for
cause or with respect to (i) any Significant Investor
Director, upon the express written instructions of the Significant
Investor(s) that designated such director in accordance with
Section 2.1.2 and (ii) (A) any director elected
pursuant to Section 2.1.2(c) and (B) any Significant
Investor Director elected by the Board with Requisite Board
Approval pursuant to Section 2.1.2(d) or (e), upon the express
written instructions of the Board with Requisite Board Approval
(each of the Significant Investor(s) designating a director
pursuant to Section 2.1.2 and the Board with Requisite Board
Approval designating the director elected pursuant to
Section 2.1.2(c) shall be referred to herein as a “
Designating Party ”). If, following election to the
Board, any member of the Board elected pursuant to
Section 2.1.2 (other than clause (f) thereof) resigns, is
removed in accordance with this Section 2.1.3, or is unable to
serve for any reason prior to the expiration of his or her term as
a director, then the applicable Designating Party may designate a
replacement. If the applicable Designating Party does not designate
a replacement, then the Voting Investors shall cause the relevant
directorship to be vacant. The Company shall take all actions as
and when reasonably requested by a Designating Party, and each
Voting Investor hereby agrees to cast all votes to which such
Voting Investor is entitled in respect of the Shares, whether at
any annual or special meeting, by written consent or otherwise, in
each case so as to (i) cause the election to the Board of any
person designated as a replacement Significant Investor Director or
as a replacement to the director elected pursuant to
Section 2.1.2(c) in accordance with this Section 2.1.3
and (ii) cause the removal of a Significant Investor Director
or the removal of the director elected pursuant to
Section 2.1.2(c) upon the express written instructions of the
applicable Designating Party to remove such Significant Investor
Director or director elected pursuant to Section 2.1.2(c). No
Voting Investor shall cast any vote to which such Voting Investor
is entitled in respect of the Shares, whether at any annual meeting
or special meeting, by written consent or otherwise to remove the
director elected pursuant to Section 2.1.2(f), except for
cause, if such director continues to serve as the Chief Executive
Officer of the Company. In the event that the director elected
pursuant to Section 2.1.2(f) no longer serves as the Chief
Executive Officer of the Company, each Voting Investor hereby
agrees to cast all votes to which such Voting Investor is entitled
in respect of the Shares, whether at any annual or special meeting,
by written consent or otherwise, in each case so as to remove such
person from the Board without cause and to appoint the Chief
Executive Officer of the Company as such director’s
replacement.
- 4 -
2.1.4 Committees . The
Company shall, and each Voting Investor shall, take all necessary
actions to, cause the Board to maintain the following committees:
(a) an audit committee, (b) a compensation committee,
(c) a nominating and governance committee and (d) such
other committees, if any, as the Board may determine to maintain;
provided that the appointment of committee members and the
delegation of the Board’s authority to a committee shall be
consistent with the by-laws of the Company; and provided ,
further , that, subject to any applicable law or rule or
regulation of any national securities exchange or market or
national securities association that is then applicable to the
Company (including applicable “director independence”
requirements), the Company shall, and each Voting Investor shall,
take all necessary actions to, cause (i) for so long as the
Ayala Significant Investor and the PEP Significant Investor,
together with their respective Affiliates, collectively continue to
own Shares representing at least twenty-five percent (25%) of
the total number of Shares owned by Ayala, PEP and their respective
Affiliates upon the Closing, except as otherwise agreed in writing
by the holders of a majority of the Shares owned by the Ayala
Significant Investor and the PEP Significant Investor, the
composition of any committee of the Board to include a number of
directors (rounded down to the nearest whole number (but not less
than one)) designated to serve on such committee by the Ayala
Significant Investor and the PEP Significant Investor (by action of
the holders of a majority of the Shares owned by the Ayala
Significant Investor and the PEP Significant Investor) equal to the
product of (x) the result obtained by dividing (A) the
number of directors then designated by the Ayala Significant
Investor and the PEP Significant Investor pursuant to Sections
2.1.2(b) and (e) by (B) the total number of directors on
the Board and (y) the total number of directors on such
committee, and (ii) for so long as the Ares Significant
Investor, together with its Affiliates, continues to own Shares
representing at least twenty-five percent (25%) of the total
number of Shares owned by Ares and its Affiliates upon the Closing,
except as otherwise agreed in writing by the Ares Significant
Investor, the composition of any committee of the Board to include
a number of directors (rounded down to the nearest whole number
(but not less than one)) designated to serve on such committee by
the Ares Significant Investor equal to the product of (x) the
result obtained by dividing (A) the number of directors then
designated by the Ares Significant Investor pursuant to Sections
2.1.2(a) and (d) by (B) the total number of directors on
the Board and (y) the total number of directors on such
committee. Notwithstanding anything to the contrary herein, no
director designated by a Significant Investor pursuant to
Section 2.1.2 shall serve as a member of any committee
established by the Board to consider any transaction as to which
such Significant Investor may have a conflict of interest, as
reasonably determined by a majority of the non-interested directors
serving on the Board.
2.1.5 Chairman of the Board; Vice
Chairman of the Board; Officers . The Company shall, and each
Voting Investor shall, take all necessary actions to, cause the
Board (a) to elect the individual serving as the
Company’s Chief Executive Officer as the Chairman of the
Board for so long as he serves as Chief Executive Officer and
(b) for so long as Mr. Fred Ayala is a member of the
Board designated by the Ayala Significant Investor and the PEP
Significant Investor pursuant to Section 2.1.2(b), to elect
Mr. Ayala as the Vice Chairman of the Board and as the
non-executive chairman of the boards of
- 5 -
directors of the Company’s subsidiaries,
EGS Corp., EGS Acquisition Corp. and eTelecare Global Solutions,
Inc. The Company and each Significant Investor agree that, upon the
Closing, subject to the Board’s and the Significant
Investors’ ability to remove such persons from such positions
after the Closing, (i) Mr. R. Scott Murray shall serve as
the Company’s Chief Executive Officer and Chairman of the
Board and (ii) Mr. Paul Joubert shall serve as a member
of the Board and the Chairman of the audit committee of the
Board.
2.1.6 Independent Directors .
Each Significant Investor agrees to reasonably cooperate with each
other Significant Investor to designate as directors pursuant to
Sections 2.1.2(a) and (b) such number of individuals who would
satisfy the applicable director independence requirements as is
necessary for the continued listing of the Common Stock on the New
York Stock Exchange, American Stock Exchange or such other national
securities exchange or market on which the Common Stock is then
listed (assuming the Board makes such affirmative determination of
independence as is required by the applicable rules or regulations
of such exchange). In the event that, after taking into account the
director designees of the Significant Investors pursuant to
Sections 2.1.2(a) and (b), the Board would not satisfy the
independence requirements necessary for the continued listing of
the Common Stock on the New York Stock Exchange, American Stock
Exchange or such other national securities exchange or market on
which the Common Stock is then listed, the Significant Investors
agree to negotiate in good faith to replace their designated
directors, to the extent necessary, in order to satisfy the
applicable director independence requirements necessary for the
continued listing of the Common Stock on the New York Stock
Exchange, American Stock Exchange or such other national securities
exchange or market on which the Common Stock is then
listed.
2.1.7 Subsidiaries . The
board of directors (and any committees thereof) of all Subsidiaries
of the Company will consist of such persons as the Company shall
designate, subject to applicable laws; provided that if a
representative of a Significant Investor is appointed to the board
of directors (or any committee thereof) of a Subsidiary of the
Company (other than EGS Corp., EGS Acquisition Corp. or eTelecare
Global Solutions, Inc.), then each of the Ares Significant
Investor, on the one hand, and the Ayala Significant Investor and
the PEP Significant Investor (by action of the holders of a
majority of the Shares owned by the Ayala Significant Investor and
the PEP Significant Investor), on the other hand, shall have the
right to appoint members to such board of directors (or committees)
in the same manner as provided for committees of the Board in
Section 2.1.4.
2.1.8 Quorum of the Board .
The greater of (a) a majority of the directors at any time in
office and (b) one-third of the number of directors
established by the Board of Directors pursuant to Section 2.2
of the Company’s By-laws shall constitute a quorum of the
Board; provided , that so long as an Ares Director, a PEP
Director or an Ayala Director serves on the Board, the presence of
an Ares Director, a PEP Director and an Ayala Director, as the case
may be, shall also be required to constitute a quorum of the Board;
provided , however, that, if an Ares Director, a PEP
Director or an Ayala Director
- 6 -
is not present at any two consecutive meetings
of the Board, then the presence of an Ares Director, a PEP Director
or an Ayala Director, as the case may be, shall not be required to
constitute a quorum of the Board for the following meeting of the
Board. If at any meeting of the Board there shall be less than such
a quorum, a majority of the directors present may adjourn the
meeting from time to time without further notice other than
announcement at the meeting, until a quorum shall be
present.
2.1.9 Quorum of a Committee of
the Board . A majority of the members of any committee of the
Board shall constitute a quorum of such committee; provided
, that, so long as an Ares Director, a PEP Director or an Ayala
Director serves on any committee of the Board, the presence of such
Ares Director, PEP Director and Ayala Director, as the case may be,
shall also be required to constitute a quorum of such committee of
the Board; provided , that, if an Ares Director, a PEP
Director or an Ayala Director that is a member of a committee is
not present at any two consecutive meetings of such committee of
the Board, then the presence of such Ares Director, PEP Director or
Ayala Director, as the case may be, shall not be required to
constitute a quorum of such committee for the following meeting of
the committee. If at any meeting of a committee of the Board there
shall be less than such a quorum, a majority of the members of such
committee present may adjourn the meeting from time to time without
further notice other than announcement at the meeting, until a
quorum shall be present.
2.2 Irrevocable Proxy . Each
Voting Investor shall, at any time it is then entitled to vote for
the election of directors to the Board, vote all of the Shares that
it is entitled to vote, or execute proxies or written consents, as
the case may be, and take all other necessary action (including
causing the Company to call a special meeting of stockholders) in
order to ensure that the composition of the Board is as set forth
in Section 2.1.2. Solely with respect to the matters
contemplated in this Section 2, each Voting Investor hereby
grants to each other Voting Investor an irrevocable proxy coupled
with an interest to vote, including in any action by written
consent, all of the Shares that it is entitled to vote in
accordance with such Voting Investor’s agreements contained
in this Section 2.
2.3 Nomination . The Company
shall cause each individual designated to serve as a director
pursuant to Section 2.1.2 to be nominated to serve as a
director on the Board, and to take all other necessary actions
(including calling a special meeting of the Board and/or
stockholders) to ensure that the composition of the Board is as set
forth in Sections 2.1.2.
2.4 Period . The foregoing
provisions of this Section 2 shall terminate, with respect to
any particular provision, on the last date permitted by applicable
law (including the rules of the Commission or any national
securities exchange or market or national securities association
upon which equity securities of the Company are listed) for such
provision to remain in effect. For the avoidance of doubt, none of
the Murray Investors, including Mr. Murray, nor any of the
Trillium Investors, including Trillium, shall be considered an
Investor for purposes of this Section 2 nor shall be bound by
the terms of this Section 2.
- 7 -
3. TRANSFER RESTRICTIONS.
3.1 Transfers Prohibited .
Except as otherwise set forth in Section 3.1.1 or 4.3, no
Investor shall Transfer any of such Investor’s Shares or any
interest therein to any other Person on or prior to the second
anniversary of the date of the Exchange Agreement, without the
prior written consent of each Significant Investor. No Investor
shall Transfer any of their respective Public Warrants or any
interest therein to any other Person (other than to the Company),
without the prior written consent of each Significant Investor. If
an Investor proposes a Transfer of a type permitted by more than
one subsection of this Section 3.1, then such Investor shall
designate, by written notice to the Company, the specific
subsection pursuant to which such Investor intends to make such
Transfer, which will be treated for all purposes under this
Agreement as the subsection under which such Transfer is
made.
3.1.1 Permissible Transfers .
The following Transfers (each a “ Permissible Transfer
”) shall not be subject to the provisions of
Section 3.1, 3.1.2, 4.1 or 4.2.
(a) Prior to the exercise of the
“drag along right” contained in Section 4.3, any
Significant Investor may Transfer any or all of such Significant
Investor’s Shares to any of such Significant Investor’s
Equity Holders; provided , that such Transfer is consummated
as a distribution-in-kind to each of such Significant
Investor’s Equity Holders on a pro rata basis. Subject to
Section 3.2, any such Equity Holder shall not be entitled to
any rights under, nor be bound by the terms of, this Agreement. Any
Shares so Transferred shall conclusively be deemed thereafter not
to be Shares under this Agreement.
(b) Subject to Section 3.2, any
Investor may Transfer any or all of such Investor’s Shares to
any of such Investor’s Permitted Transferees, so long as such
Permitted Transferee agrees to be bound by the terms of this
Agreement in accordance with Section 3.2 (if not already bound
hereby). Any Shares so Transferred shall conclusively be deemed
thereafter to be Shares under this Agreement. In the event that a
Permitted Transferee holding any Shares ceases to qualify, or
expects to cease to qualify, as a Permitted Transferee in relation
to the initial transferring Investor from whom or which such
Permitted Transferee or any previous Permitted Transferee of such
initial transferring Investor received such Shares (an “
Unwinding Event ”), prior to such Unwinding Event,
such initial transferring Investor shall take all actions necessary
to effect a Transfer of all the Shares held by the relevant
Permitted Transferee either back to such Investor or, pursuant to
this Section 3.1.1, to another Person that qualifies as a
Permitted Transferee of such initial transferring
Investor.
(c) Transfers by a Participating
Seller pursuant to Section 4.2 or 4.3, as
applicable.
(d) Transfers pursuant to a tender
offer subject to Section 14(d)(1) of the Exchange Act (other
than a tender offer made by an Investor).
- 8 -
(e) Transfers pursuant to Rule 144
or an effective registration statement under the Securities
Act.
3.1.2 Post Second Anniversary
Transfers . After the second anniversary of the date of the
Exchange Agreement, each Investor shall have the right to Transfer
any or all of such Investor’s Shares or any interest therein
to any other Person, subject to the “right of first
offer” provisions contained in Section 4.1 and the
“tag along” provisions contained in Section 4.2;
provided , that any Permissible Transfer shall not be
subject to the “right of first offer” provisions
contained in Section 4.1 or the “tag along”
provisions contained in Section 4.2.
3.2 Transferees to Become
Parties . Any transferee receiving Shares in a Transfer
pursuant to Section 3.1.1 or 3.1.2 (other than in an Exempt
Transfer) shall become an Investor party to this Agreement and be
subject to the terms and conditions of, and be entitled to enforce,
this Agreement, to the same extent, and in the same capacity, as
the Investor that Transfers such Shares to such transferor. Prior
to the Transfer of any Shares to any transferee pursuant to
Section 3.1.1 or 3.1.2 (other than an Exempt Transfer), and as
a condition thereto, the Investor effecting such Transfer shall
cause such transferee to deliver to the Company and the other
Investors a written agreement substantially in the form of
Exhibit A (or in form and substance that is otherwise
reasonably satisfactory to the Company and a Requisite Majority),
to be bound by the terms and conditions of this Agreement, to the
extent described in the preceding sentence.
3.3 Restrictions on Transfers to
Competitors . Notwithstanding anything in this Agreement to the
contrary, except (i) in connection with a “drag-along
sale” pursuant to Section 4.3, (ii) a Change of
Control transaction, or (iii) a Transfer unanimously approved
by all of the Significant Investors and Mr. Murray (for so
long as he is the Chief Executive Officer of the Company), no
Investor shall Transfer any of such Investor’s Shares to a
Company Competitor.
3.4 Other Restrictions on
Transfer . The restrictions on transfer contained in this
Agreement are in addition to any other restrictions on transfer to
which an Investor may be subject, including any restrictions on
transfer contained in the Company’s certificate of
incorporation, stock option or warrant agreement, stock purchase
agreement or other agreement to which such Investor is a party or
by which such Investor is bound or any applicable lock up rules and
regulations of any national securities exchange or market or
national securities association.
3.5 Impermissible Transfers .
Any Transfer of Shares not made in compliance with the terms of
this Section 3 shall be null and void ab initio , and
the Company shall not in any way give effect to any such
Transfer.
- 9 -
4. RIGHT OF FIRST OFFER, TAG ALONG RIGHTS AND
DRAG ALONG RIGHTS.
4.1 Right of First Offer . If
an Investor or group of Investors (collectively, the “
Prospective Selling Investor ”) desires to Transfer
any Shares (the “ Offered Shares ”), other than
in a Permissible Transfer, then the provisions of this
Section 4.1 will apply to such Transfer.
4.1.1 Notice . The
Prospective Selling Investor shall, prior to any such proposed
Transfer, furnish a written notice of its desire to do so (the
“ Transfer Notice ”) to the Company and each of
the Significant Investors. The Transfer Notice shall include the
number of Offered Shares.
4.1.2 Company’s Option to
Purchase . Subject to Section 4.2, except in the event of
a proposed Transfer that would result in a Change of Control (in
which case only the Significant Investors shall have the right to
purchase the Offered Shares), the Company shall have the first
option to offer to purchase, for cash payable at the closing of
such Transfer, all or any part of the Offered Shares. The Company
may exercise such option, subject to approval by a majority of the
disinterested members of the Board, no later than ten
(10) days after such Transfer Notice is delivered, by
delivering a written notice to the Prospective Selling Investor
setting forth the Company’s offer to purchase the Offered
Shares, including (i) the cash price per Share at which the
Company is willing to purchase the Offered Shares and (ii) the
maximum number of Offered Shares the Company is willing to purchase
(the “ Company Exercise Notice ”). In the event
the Company does not exercise its option within such 10-day period
with respect to all of the Offered Shares, the Company shall, by
the last day of such period, give written notice of that fact to
the Significant Investors (the “ Investor Notice
”). The Investor Notice shall specify the number of Offered
Shares that the Company has not offered to purchase (the “
Remaining Shares ”).
4.1.3 Investors’ Option to
Purchase . Subject to Section 4.2, each other Significant
Investor shall have an option, exercisable for a period of ten
(10) days from the date of delivery of the Investor Notice, to
offer to purchase, for cash payable at the closing of such
Transfer, all or any portion of the Remaining Shares. Such option
shall be exercised by delivery by such Significant Investor of
written notice to the Prospective Selling Investor and the Company
setting forth the principal terms and conditions of the Significant
Investor’s offer to purchase the Offered Shares, including
(i) the cash price per Share at which such Significant
Investor is willing to purchase the Offered Shares and
(ii) the maximum number of Offered Shares such Significant
Investor is willing to purchase (the “ Investor Exercise
Notice ”). If the number of Offered Shares so specified
by all other Significant Investors exceeds the total number of
Remaining Shares, the Remaining Shares available for purchase by
each such Significant Investor shall be allocated to such
Significant Investor on a pro rata basis according to the number of
Shares then owned by each such Significant Investor. The option to
offer to purchase (and all related rights) under this
Section 4.1 shall terminate with respect to a Significant
Investor on the first date on which such Significant Investor no
longer owns Shares representing at least seven and one-half percent
(7.5%) of the then outstanding shares of Common
Stock.
- 10 -
4.1.4 Acceptance or Rejection of
Exercise Notice .
(a) The Prospective Selling Investor
shall have (i) ten (10) days from the date of delivery of
the Company Exercise Notice or (ii) if an Investor Notice is
delivered, ten (10) days from the date of delivery of the
Investor Exercise Notice(s), to accept or reject in writing any
offer by the Company or any Significant Investor (the “
Acceptance Period ”); provided, that if the accepted
offers specify a number of shares in excess of the number of
Offered Shares, the Offered Shares available for purchase by each
offeror shall be allocated in the manner that will provide the
maximum aggregate purchase price. If more than one allocation
provides the maximum aggregate purchase price, the Offered Shares
shall be allocated (i) first, to the Company, if the
Company’s offer has been accepted and such allocation does
not reduce the aggregate offering price and (ii) thereafter to
each other Significant Investor whose offer has been accepted,
first based on highest offer price, and thereafter on a pro rata
basis according to the number of Shares then owned by each such
Significant Investor. Subject to the foregoing, if the Prospective
Selling Investor accepts an offer, the Prospective Selling Investor
shall be bound and obligated to Transfer, and the applicable
offeror shall be bound and obligated to purchase, the Offered
Shares for a purchase price equal to the offer price, payable in
cash.
(b) If (i) the Prospective
Selling Investor rejects the offer by the Company and/or the
Significant Investor(s) or (ii) the Company and/or the
Significant Investor(s) do not submit a Company Exercise Notice or
an Investor Exercise Notice, as applicable, within the requisite
time period, then the Prospective Selling Investor may Transfer all
of the Offered Shares to any other Person or Persons, subject to
Section 4.2; provided , that
(i) if the Company and/or any
Significant Investor(s) offered to purchase all of the Offered
Shares, no such Transfer may be made for a per Share price lower
than or equal to the highest weighted average price per Share
pursuant to such offer that would have resulted in all of the
Offered Shares being purchased (it being understood that
(x) if any portion of the consideration to be paid by a
transferee is in a form other than cash, the value thereof shall be
conclusively determined in good faith by the Prospective Selling
Investor and (y) in determining the value of the consideration
received from the transferee, the Prospective Selling Investor may
include its good faith determination of the value of all other
potential benefits, including tax benefits, earn-outs and similar
items, and other terms and conditions) and
(ii) if such Transfer is not
completed by the end of the 270th day after the last day of the
Acceptance Period ( provided , that, if such Transfer is
subject to any regulatory approval, such 270 day period shall be
extended until the expiration of five (5) business days after
all such approvals have been received, but in no event later than
three hundred (300) days following the last day of the
Acceptance
- 11 -
Period), the Transfer Notice shall be null and
void, and it shall be necessary for a separate Transfer Notice to
be furnished, and the terms and provisions of this Section 4.1
separately complied with, in order to consummate such a subsequent
Transfer pursuant to this Section 4.1.
(c) If the Prospective Selling
Investor accepts the offer contained in the Company Exercise Notice
and/or the Investor Exercise Notice(s), as applicable, subject to
Section 4.4, the closing of such Transfer shall take place at
the offices of the Company within ten (10) days after the last
day of the Acceptance Period ( provided , that, if such
Transfer is subject to any regulatory approval, such ten
(10) day period shall be extended until the expiration of five
(5) business days after all such approvals have been received,
but in no event later than sixty (60) days following the last
day of the Acceptance Period). The Prospective Selling
Investor’s obligation to make representations and warranties
to the Company or a Significant Investor shall be limited in each
case to representations and warranties to (i) the unencumbered
title to the Offered Shares, (ii) the power, authority and
legal right to Transfer such Offered Shares and (iii) the
absence of any Adverse Claim with respect to such Offered
Shares.
4.1.5 Indirect Transfers . No
Investor shall permit a direct or indirect equity holder to
Transfer any direct or indirect equity interests in such Investor
(other than Transfers of equity interests of (i) Ares
Corporate Opportunities Fund II, L.P. or any of its affiliated
investment funds (or the general partners thereof),
(ii) Providence Equity Partners VI International, L.P. or any
of its affiliated investment funds (or the general partners
thereof), or (iii) Ayala Corporation) in a Transfer of a type
that would be subject to this Section 4.1 if such Transfer
involved a Transfer of Shares by such Investor (any such Transfer
of any such equity interests, an “ Indirect Transfer
”), unless such Investor causes to be provided to each other
Investor “rights of first offer” and “tag
along” rights with respect to such Indirect Transfer that are
substantially equivalent to the “rights of first offer”
and “tag along” rights set forth in this
Section 4.1 and Section 4.2 and subject to obligations
and other terms and conditions that are substantially equivalent to
those set forth in this Section 4.1 and
Section 4.2.
4.2 Tag Along . If the
Company and the Significant Investors do not purchase all of the
Offered Shares specified in a Transfer Notice in accordance with
the provisions set forth in Section 4.1 and the Prospective
Selling Investor proposes a Transfer with a Third Party, the
Prospective Selling Investor shall, to the extent such Transfer is
subject to this Section 4.2, by written notice (the “
Tag Along Notice ”) to each of the other Investors
(the “ Tag Along Offerees ”), first offer the
Tag Along Offerees the opportunity to participate in such Transfer
in accordance with this Section 4.2 (a “ Tag Along
Sale ”).
4.2.1 The Tag Along Notice shall
identify (i) the class and number of shares of Offered Shares
proposed to be sold by the Prospective Selling Investor,
(ii) the fraction expressed as a percentage, determined by
dividing the number of Shares to be purchased from the Prospective
Selling Investor in such Tag Along Sale by the number of Shares
held by such Prospective Selling Investor (the “ Tag Along
Sale Percentage ”) (it being understood that the Company
shall reasonably cooperate with the Prospective
- 12 -
Selling Investor in respect of the determination
of the Tag Along Sale Percentage), (iii) the consideration for
which the Transfer is proposed to be made, (iv) the name and
address of each proposed Third Party transferee, (v) the
proposed Transfer date and (vi) all other material terms and
conditions of the Tag Along Offer, including the form of the
proposed agreement, if any, and a firm offer by each proposed Third
Party transferee to purchase the Offered Shares.
4.2.2 Exercise . Within seven
(7) business days after the date of delivery of the Tag Along
Notice by the Prospective Selling Investor to each Tag Along
Offeree, each Tag Along Offeree desiring to make an offer to
include Shares in the proposed Transfer (each a “
Participating Seller ” and, together with the
Prospective Selling Investor, collectively, the “ Tag
Along Sellers ”) shall furnish a written notice (the
“ Tag Along Offer ”) to the Prospective Selling
Investor indicating the number of Shares which such Participating
Seller desires to have included in the proposed Transfer (not in
any event to exceed the Tag Along Sale Percentage of the total
number of Shares held by such Tag Along Offeree). Each Tag Along
Offeree who does not make a Tag Along Offer in compliance with the
above requirements, including the time period, shall have waived
and be deemed to have waived all of such holder’s rights with
respect to such Transfer, and, the Tag Along Sellers shall
thereafter be free to Transfer to the Prospective Buyer, at a per
Share price no greater than the per Share price set forth in the
Tag Along Notice and on other terms and conditions that are, in all
material respects, the same as those set forth in the Tag Along
Notice, without any further obligation to such non-accepting Tag
Along Offeree pursuant to this Section 4.2. The Prospective
Selling Investor shall use its commercially reasonable efforts to
interest the Prospective Buyer in purchasing, in addition to the
Offered Shares, at the same price per Share and on the terms and
conditions set forth in the Transfer Notice, all of the Shares the
Participating Sellers wish to sell. If the Prospective Buyer does
not wish to purchase all of the Shares made available by the Tag
Along Sellers, then each Tag Along Seller shall be entitled to
sell, at the same price per Share and on the terms and conditions
set forth in the Transfer Notice, a portion of the Shares being
sold to the Prospective Buyer, in the same proportion as such Tag
Along Seller’s ownership of Shares bears to the aggregate
number of Shares owned by all of the Tag Along Sellers. If the
Participating Sellers do not elect to sell the full number of
Shares which they are entitled to sell pursuant to this
Section 4.2.2, the Prospective Selling Investor shall be
entitled to sell to the Prospective Buyer, according to the terms
and conditions of the Transfer Notice, that number of its own
Shares which equals the difference between the number of Shares
desired to be purchased by the Prospective Buyer and the number of
Shares the Participating Sellers sell pursuant to this
Section 4.2.2.
4.2.3 Irrevocable Offer .
Subject to Section 4.2.4, the offer of each Investor pursuant
to Section 4.2.2 to sell Shares under this Section 4.2 on
the terms and conditions set forth in the Tag Along Notice shall be
irrevocable, and such Participating Seller shall be bound and
obligated to Transfer in the proposed Transfer, on the terms and
conditions set forth in the Tag Along Notice, such number of Shares
as was specified in such Participating Seller’s Tag Along
Offer pursuant to Section 4.2.2.
- 13 -
4.2.4 Additional Compliance .
If, prior to consummation, the terms of the proposed Transfer shall
change with the result that the per Share price to be paid in such
proposed Transfer shall be lower than the offer price set forth in
the Tag Along Notice, the number of Shares to be purchased by the
Prospective Buyer shall be different than the number of Offered
Shares specified in the Tag Along Notice or the other terms or
conditions of such proposed Transfer shall be different than those
set forth in the Tag Along Notice (other than (i) an increase
in the number of Offered Shares to include all of the Shares the
Participating Sellers wish to sell or (ii) a change in the
form of consideration where the per Share price to be paid is with
Marketable Securities with a value equal to or greater than the
offer price), then, in any such case, the Tag Along Notice shall be
null and void, and it shall be necessary for a separate Tag Along
Notice to be furnished, and the terms and provisions of
Section 4.1 and this Section 4.2 separately complied
with, in order to consummate such proposed Transfer pursuant to
this Section 4. In addition, if the Prospective Selling
Investor has not completed the proposed Transfer upon the terms set
forth in the Tag Along Notice by the end of the 90th day after the
date of delivery of the Tag Along Notice to the Company and each of
the other Investors, each Participating Seller shall be released
from such Participating Seller’s obligations under
Section 4.2, the Transfer Notice shall be null and void, and
it shall be necessary for a separate Transfer Notice to be
furnished, and the terms and provisions of Section 4.1 and
this Section 4.2 separately complied with, in order to
consummate such proposed Transfer pursuant to Section 4.1 and
this Section 4.2.
4.3 Sale Event Drag Along .
Subject to compliance with Section 6.1(a), 6.2(a) or 6.2(b),
as applicable, if one or more Significant Investors (such
Significant Investors, the “ Dragging Investors
”) propose to Transfer any Shares (or to cause the Transfer
of all or substantially all of the assets of the Company) to a
Prospective Buyer that is not an Affiliate of any such Dragging
Investor in a transaction, including a merger, or a series of
related transactions that, after giving effect to the provisions of
this Section 4.3, would constitute a Change of Control, then
subject to compliance with Section 4.1, the provisions of this
Section 4.3 will apply to such Transfer and each Investor
agrees to Transfer to such Prospective Buyer in connection with
such transaction or transactions, as the case may be, a percentage
of the Shares owned by such Investor that is equal to the
percentage of the aggregate number of Shares then owned by all of
the Dragging Investors that are proposed to be Transferred to such
Prospective Buyer (the “ Drag Along Sale Percentage
”). For the avoidance of doubt, none of the Murray Investors,
including Mr. Murray, nor any of the Trillium Investors,
including Trillium, shall be considered an Investor for purposes of
this Section 4.3 nor shall be bound by the terms of this
Section 4.3.
4.3.1 Exercise . The Dragging
Investors shall furnish a written notice (the “ Drag Along
Sale Notice ”) to the Company at least ten
(10) business days prior to the consummation of such proposed
Transfer, and the Company shall promptly furnish any such Drag
Along Sale Notice to each Investor other than the Dragging
Investors. The Drag Along Sale Notice shall set forth the principal
terms and conditions of the
- 14 -
proposed Transfer insofar is it relates to the
Shares, including (a) the number of Shares to be acquired from
the Dragging Investor, (b) the Drag Along Sale Percentage,
(c) the per Share consideration to be received in the proposed
Transfer, including the form of consideration (if other than cash),
(d) the name and address of the Prospective Buyer and
(e) if known, the proposed closing date. If the Dragging
Investor consummates the proposed Transfer to which reference is
made in the Drag Along Sale Notice, each other Investor (each, a
“ Participating Seller, ” and together with the
Dragging Investors, the “ Drag Along Sellers ”)
shall be bound and obligated to Transfer the Drag Along Sale
Percentage of such Investor’s Shares in the proposed Transfer
on the same terms and conditions as the Dragging Investor with
respect to each Share Transferred (subject to the limitations set
forth in the proviso to the first sentence of Section 4.4.2).
If, at the end of the 270th day after the date of delivery of the
Drag Along Sale Notice, the Dragging Investor has not completed the
proposed Transfer, the Drag Along Sale Notice shall be null and
void, each Participating Seller shall be released from its
obligation under the Drag Along Sale Notice and it shall be
necessary for a separate Drag Along Sale Notice to be furnished and
the terms and provisions of this Section 4.3 separately
complied with, in order to consummate such proposed Transfer
pursuant to this Section 4.3.
4.3.2 Waiver of Appraisal
Rights . Each Investor agrees not to demand or exercise, and to
the fullest extent permitted by applicable law hereby waives,
appraisal rights under Section 262 of the DGCL or otherwise
with respect to any transaction subject to this Section 4.3,
whether or not such appraisal rights are otherwise
available.
4.3.3 Drag Along Sale
Transactions . If a vote of holders of shares of capital stock
of the Company (or any class or series of shares of capital stock
of the Company) is required under any applicable law or rule or
regulation of any national securities exchange or market or
national securities association applicable to the Company, in each
case in connection with a transaction being implemented pursuant to
this Section 4.3 or is determined to be otherwise desirable by
the Dragging Investors, each other Investor agrees to cast all
votes to which such Investor is entitled in respect of the Shares,
whether at any annual or special meeting, by written consent or
otherwise, in such manner as such Dragging Investors may instruct
by written notice, to approve any sale, merger, consolidation,
reorganization or any other transaction involving the Company or
any of its Subsidiaries (or all or any portion of their respective
assets) in connection with, or in furtherance of, the exercise by
such Dragging Investors of its rights under this Section 4.3
and in all cases consistent with the provisions thereof. The
Company shall take all actions reasonably requested by the Dragging
Investors in connection with a transaction contemplated by this
Section 4.3.
4.4 Miscellaneous Sale
Provisions . Notwithstanding anything to the contrary herein,
the provisions of Section 4.4 shall apply to any Transfer to
which Section 4.1, 4.2 or 4.3 applies.
- 15 -
4.4.1 Certain Legal
Requirements . If the consideration to be paid for Shares in a
Transfer pursuant to Section 4.3 includes any securities, and
the receipt thereof by a Participating Seller would require under
applicable law (a) the registration or qualification of such
securities or of any Person as a broker or dealer or agent with
respect to such securities where such registration or qualification
would not otherwise be required for the Transfer by the Prospective
Selling Investor or (b) the provision to any Drag Along Seller
of any specified information regarding the Company or any of its
Subsidiaries, such securities or the issuer thereof, in each case
that is not otherwise required to be provided for the Transfer by
the Prospective Selling Investor, then such Participating Seller
shall not have the right to Transfer Shares in such Transfer. In
such event, the Prospective Selling Investor will have the right,
but not the obligation, to cause to be paid to such Participating
Seller in lieu of such securities, against surrender of the Shares
(in accordance with Section 4.4.5 hereof) that would have
otherwise been Transferred by such Participating Seller to the
Prospective Buyer in the Transfer, an amount in cash equal to the
fair market value of such Shares as of the date such securities
would have been delivered in exchange for such Shares, as
determined in good faith by the Board, and thereupon such Drag
Along Seller shall be obligated to Transfer Shares in such Transfer
in accordance with Section 4.3.
4.4.2 Further Assurances .
The Company and each Participating Seller whether in such
Participating Seller’s capacity as a stockholder, director or
officer of the Company or otherwise, shall use its reasonable best
efforts to take or cause to be taken all such actions as may be
necessary or reasonably desirable in order expeditiously to
consummate each Transfer pursuant to Section 4.1, 4.2 or 4.3
and any related transactions, including executing, acknowledging
and delivering consents, assignments, waivers and other documents
or instruments; furnishing information and copies of documents;
filing applications, reports, returns, filings and other documents
or instruments with governmental authorities; and otherwise
cooperating with the Prospective Selling Investor and the
Prospective Buyer; provided , however , that
Participating Sellers shall be obligated to become liable in
respect of any representations, warranties, covenants, indemnities
or otherwise to the Prospective Buyer in connection with such
Transfer solely to the extent provided in the immediately following
sentence. Without limiting the generality of the foregoing, each
Participating Seller agrees to execute and deliver such agreements
as may be reasonably specified by the Prospective Selling Investor
to which such Prospective Selling Investor will also be party,
including agreements to (a)(i) make individual representations,
warranties, covenants and other agreements, in each case as to the
unencumbered title to its Shares and the power, authority and legal
right to Transfer such Shares and the absence of any Adverse Claim
with respect to such Shares and (ii) be liable as to such
representations, warranties, covenants and other agreements, in
each case to the same extent as the Prospective Selling Investor is
liable for the comparable representations, warranties, covenants
and agreements made by it or on its behalf (with any limit on
liability applied based on the relative value of their respective
Shares), and (b) be liable (whether by purchase price
adjustment, indemnity payments or otherwise, including pro rata
participation in any escrow or holdback applicable to the sellers)
in respect of
- 16 -
representations, warranties, covenants and
agreements in respect of the Company and its Subsidiaries in
connection with such Transfer; provided , however ,
that the aggregate amount of liability described in this clause
(b) shall not exceed the lesser of (x) such Participating
Seller’s pro rata share of any such liability, to be
determined in accordance with such Participating Seller’s
portion of the aggregate proceeds to all Participating Sellers and
Prospective Selling Investors in connection with such Transfer and
(y) the proceeds to such Participating Seller in connection
with such Transfer. In connection with any governmental or
regulatory approval required for any Transfer pursuant to
Section 4.1, 4.2 or 4.3, including any such required approval
of the DOJ or FTC, the Company shall file such applications and
other materials as are necessary or desirable to file in order to
obtain such governmental or regulatory approval, and each Investor
shall cooperate with the Company and promptly provide it with any
and all information, certifications and other materials necessary
or otherwise reasonably requested by the Company to complete the
filing of such applications and materials and to obtain such
governmental or regulatory approval. Without limitation to the
foregoing sentence, the Company shall use its reasonable best
efforts to obtain such governmental or regulatory approval as
promptly as practicable, including (a) diligently prosecuting
any such applications and other filings and, when applicable,
opposing any petitions to deny, or any other objections filed with
respect to, any such applications or other filings, and
(b) promptly taking all other actions reasonably requested by
the Prospective Selling Investor as necessary or desirable to
facilitate obtaining such governmental or regulatory
approval.
4.4.3 Sale Process . The
Prospective Selling Investor shall, in its sole discretion, decide
whether or not to pursue, consummate, postpone or abandon any
proposed Transfer and the terms and conditions thereof, except as
provided in Section 4.1. No Investor or Affiliate of any
Investor will have any liabil